scispace - formally typeset
K

Kazuhiro Sanpei

Researcher at Niigata University

Publications -  30
Citations -  2065

Kazuhiro Sanpei is an academic researcher from Niigata University. The author has contributed to research in topics: Trinucleotide repeat expansion & Spinocerebellar ataxia. The author has an hindex of 15, co-authored 28 publications receiving 1892 citations. Previous affiliations of Kazuhiro Sanpei include University of Tokyo.

Papers
More filters
Journal ArticleDOI

Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT.

TL;DR: A novel strategy, the direct identification of repeat expansion and cloning technique (DIRECT), which allows selective detection of expanded GAG repeats and cloning of the genes involved and will dramatically accelerate the search for causative genes of neuropsychiatric diseases caused by trinucleotide repeat expansions.
Journal ArticleDOI

Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy.

TL;DR: It is shown that abnormal expansions of TTTCA and TTTTA repeats in intron 4 of SAMD12 cause benign adult familial myoclonic epilepsy (BAFME), and RNA toxicity as the mechanism underlying disease pathogenesis is identified.
Journal ArticleDOI

Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease

TL;DR: The disease phenotype is significantly more severe and had an early age of onset (16 years), which suggests that the expanded allele in the MJD1 gene could exert its effect either by a dominant negative effect (putatively excluded in HD) or by a gain of function effect as proposed for HD.
Journal ArticleDOI

Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody

TL;DR: Data indicate that most patients with myeloperoxidase-ANCA-positive hypertrophic pachymeningitis should be categorized as having the central nervous system-limited form of ANCA-associated vasculitis, consistent with the concept of ophthalmic-, pulmonary- or renal-limited vasculopathy.